Skip to main content

Table 1 Baseline characteristics of all patients

From: Haemodynamic effects of plasma-expansion with hyperoncotic albumin in cirrhotic patients with renal failure: a prospective interventional study

Age (years)

56 (± 8)

Gender (m/f)

33/17

MELD-score

28 (± 9)

Child-Pugh-score

12 (± 2)

Child-Pugh class (B/C)

10/40

Serum creatinine (μmol/l)

256 (± 150)

Fractional excretion of Sodium (%)

0.040 (± 0.026)

Creatinine clearance (ml/min)

22 (± 16)

CVP (mmHg)

11 (± 5)

GEDVI (ml/m2); (n: 680–800)

675 (± 138)

CI (L/min/m2); (n: 3–5)

4.1 (± 1.2)

SVI (ml/m2); (n: 40–60)

48 (± 13)

HR (bpm)

88 (± 20)

SVRI (dyn s/cm5/m2); (n:1700–2400)

1898 (± 1015)

compa (ml/mmHg)

1.58 (± 0.57)

MAP (mmHg)

79 (± 14)

CPI (mmHg L/min/m2)

0.71 (± 0.27)

  1. MELD: Model of End-Stage Liver Disease; CVP: Central Venous Pressure; GEDVI: Global End-Diastolic Volume Index; CI: Cardiac Index; SVI: Stroke Volume Index; HR: Heart Rate; SVRI: Systemic Vascular Resistance Index; compa: Arterial Compliance; MAP: Mean Arterial Pressure; CPI: Cardiac Power Index